Motiva stock pivots to highways and rail after airport sale
National HealthCare stock: Q3 revenue rises 6.6% as GAAP profit drops
Destination XL stock: Board opposes FullBeauty merger issuance
International Flavors & Fragrances Raises 2026 Guidance Floors
Kimco Realty stock: UBS raises price target by USD 4
First Watch stock sets long-term targets for 15% EBITDA growth
My Size stock faces delayed third-quarter filing after information delays
Log Commercial stock posts 9.2% net income growth in Q3
JBG SMITH stock: Revenue rises as quarterly loss widens
Light stock posts BRL 56 million Q3 loss after restructuring
Hubbell stock target cut by JPMorgan to USD 470
OrthoPediatrics stock gets full commercial launch for VerteGlide
Investcorp Credit Management BDC stock to merge with BCP
Rosenbauer's Profit Gain Masks a Deepening Cash Drain
Verbio's Fivefold EBITDA Jump Wins Two Buy Calls, Yet the Stock Keeps Sliding
Falabella stock: 2027 investment plan tops US$1.1 billion
M. Dias Branco stock slips as Q3 net income falls 27%
ESAB stock outlook cut as organic growth forecast slows
Corporativo Fragua stock: Q3 sales rise 9.5% as margins narrow
First Community stock: Q3 net income reaches USD 8.04 million
Locaweb stock grows revenue 5.1% as adjusted EBITDA expands
LifeVantage stock reports 22% revenue drop in fiscal Q1
Ingevec stock: Nine-month net income rises 27.1%
Lindsay Corporation stock enters new governance phase after Vision One pact
Minerva Foods stock gets new buyback after prior plan ends
Fluent stock: Q3 revenue rises 14% as commerce media doubles
MBRF Global Foods stock: Q3 net profit rises 123.5% on tax gain
Evertec stock: Credit deal extends maturities and lifts liquidity
Enjoei stock: Q3 revenue rises as record GMV masks EBITDA loss
Grupo Energia Bogota stock posts COP 669 billion Q3 net income
Lifetime Brands stock: Board lifts buyback authorization to USD 20 million
Franklin Covey stock: Fiscal 2026 EBITDA rises as revenue slips
Mallplaza stock reports 8.7% EBITDA growth in third quarter
ImageneBio stock: Q3 loss narrows as clinical trials advance
Studio City stock: Q3 revenue falls to USD 163.3 million
Fibra Macquarie stock: Monterrey completes 98.12% takeover